Skip to main content
TipRanks
Go Ultimate75% OFF

COSMOS Pharmaceutical Corporation (3349) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

COSMOS Pharmaceutical Corporation has a market cap or net worth of JPY 520.98B. The enterprise value is JPY 544.51B.

Market Cap
JPY 520.98B
Enterprise Value
JPY 544.51B

Share Statistics

COSMOS Pharmaceutical Corporation has 80,001,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
80,001,600
Owned by Insiders
―
Owned by Institutions
7.55%

Financial Efficiency

COSMOS Pharmaceutical Corporation’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 8.37%.

Return on Equity (ROE)
0.11
Return on Assets (ROA)
0.05
Return on Invested Capital (ROIC)
8.37%
Return on Capital Employed (ROCE)
0.12
Revenue Per Employee
183.75M
Profits Per Employee
5.36M
Employee Count
5,984
Asset Turnover
1.84
Inventory Turnover
8.78

Valuation Ratios

The current PE Ratio of COSMOS Pharmaceutical Corporation is 15.87. COSMOS Pharmaceutical Corporation’s PEG ratio is 4.39.

PE Ratio
15.87
PS Ratio
0.46
PB Ratio
1.77
Price to FCF
-43.67
Price to Operating Cash Flow
8.67
PEG Ratio
4.39

Income Statement

In the last 12 months, COSMOS Pharmaceutical Corporation had revenue of 1.10T and earned 32.05B in profits. Earnings per share was 404.33.

Revenue
1.10T
Gross Profit
229.68B
Operating Income
42.35B
Pretax Income
44.22B
Net Income
32.05B
EBITDA
66.48B
Earnings Per Share (EPS)
404.33

Cash Flow

In the last 12 months, operating cash flow was 58.79B and capital expenditures -70.46B, giving a free cash flow of -11.67B billion.

Operating Cash Flow
58.79B
Free Cash Flow
-11.67B
Free Cash Flow per Share
-147.27

Dividends & Yields

COSMOS Pharmaceutical Corporation pays an annual dividend of JPY 42.00, resulting in a dividend yield of 1.29%

Dividend Per Share
JPY 42.00
Dividend Yield
1.29%
Payout Ratio
20.28%
Free Cash Flow Yield
-2.31%
Earnings Yield
6.36%

Stock Price Statistics

Beta
-0.14
52-Week Price Change
-16.50%
50-Day Moving Average
6360.02
200-Day Moving Average
6406.33
Relative Strength Index (RSI)
50.60
Average Volume (3m)
468.54K

Important Dates

COSMOS Pharmaceutical Corporation upcoming earnings date is Jan 08, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 13, 2026
Next Earnings Date
Jan 08, 2027
Ex-Dividend Date
May 28, 2027

Financial Position

COSMOS Pharmaceutical Corporation as a current ratio of 0.77, with Debt / Equity ratio of 27.66%

Current Ratio
0.77
Quick Ratio
0.36
Debt to Market Cap
0.16
Net Debt to EBITDA
0.26
Interest Coverage Ratio
72.90

Taxes

In the past 12 months, COSMOS Pharmaceutical Corporation has paid 12.17B in taxes.

Income Tax
12.17B
Effective Tax Rate
0.28

Enterprise Valuation

COSMOS Pharmaceutical Corporation EV to EBITDA ratio is 7.70, with an EV/FCF ratio of -45.75.

EV to Sales
0.48
EV to EBITDA
7.70
EV to Free Cash Flow
-45.75
EV to Operating Cash Flow
9.08

Balance Sheet

COSMOS Pharmaceutical Corporation has JPY 39.38B in cash and marketable securities with JPY 68.48B in debt, giving a net cash position of -JPY 29.10B billion.

Cash & Marketable Securities
JPY 39.38B
Total Debt
JPY 68.48B
Net Cash
-JPY 29.10B
Net Cash Per Share
-JPY 363.77
Tangible Book Value Per Share
JPY 3,625.88

Margins

Gross margin is 21.07%, with operating margin of 3.83%, and net profit margin of 2.88%.

Gross Margin
21.07%
Operating Margin
3.83%
Pretax Margin
3.99%
Net Profit Margin
2.88%
EBITDA Margin
6.22%
EBIT Margin
3.96%

Analyst Forecast

The average price target for COSMOS Pharmaceutical Corporation is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
8.99%
EPS Growth Forecast
3.61%

Scores

Smart Score
―
AI Score
58